Skip to main content
. 2020 Mar 18;15(3):e0230499. doi: 10.1371/journal.pone.0230499

Fig 2. Systemic disease measures are not significantly impacted by OP treatment in MRL/lpr mice.

Fig 2

Splenomegaly in the same mice as in Fig 1 was determined by absolute spleen weight (A) and as spleen to body weight ratio (B). (C) Percentages of activated/memory T cells (CD3+ CD44+ CD62L-) were measured in spleen by flow cytometry. IgG levels were measured by ELISA in serum samples collected one day prior to treatment (Pre-treatment) and one day prior to euthanasia (Endpoint) with absolute levels (D) and change in levels from Pre-treatment to Endpoint (E) presented. Means with standard deviations are presented. Water, water-treated MRL/lpr mice; OP, OP-treated MRL/lpr mice; MpJ, MRL/MpJ (untreated) mice.